MedPath

Prognostic Analysis of Distal Pancreatectomy for Pancreatic Body and/or Tail Cancer

Not Applicable
Conditions
pancreatic cancer
Registration Number
JPRN-UMIN000041642
Lead Sponsor
Shizuoka Cancer Center
Brief Summary

Overall survival (OS) (MST 28.9 month vs. 27.3 months, P = 0.915) was comparable between the PV contact < 180 degree (n = 152) and PV contact > 180 degree (n=16) groups. OS (MST 28.3 months vs. 26.4 months, P = 0.136) were comparable between the PV contact (n = 168) and CeA contact (n = 172) groups. Cox proportional hazards analysis revealed PV contact (hazard ratio, 1.295; P = 0.003) as independent prognostic factors for OS.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
1693
Inclusion Criteria

Not provided

Exclusion Criteria

Histologic type was other than invasive ductal carcinoma Multiple or asynchronic carcinoma

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath